Who owns Pds Biotechnology Ord?
- Ticker: PDSB
- CUSIP Number: 70465t107
Tip: Access positions for across all investors
Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Pds Biotechnology Ord stock
Who bought or sold Pds Biotechnology Ord this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BlackRock | 1.8M | $9.1M | 4% | Sep 2023 |
|
Vanguard Group | 1.5M | $7.5M | 0% | Dec 2023 |
|
Geode Capital Management | 601k | $3.0M | 4% | Sep 2023 |
|
State Street Corporation | 505k | $2.5M | 10% | Sep 2023 |
|
Susquehanna International | 493k | $2.5M | 33% | Sep 2023 |
|
Citadel Advisors | 406k | $2.0M | 20% | Dec 2023 |
|
Tang Capital Management | 400k | $2.0M | 0% | Dec 2023 |
|
Integrys Wealth Advisors | 337k | $1.7M | 2% | Dec 2023 |
|
Northern Trust | 246k | $1.2M | 3% | Sep 2023 |
|
LPL Financial | 235k | $1.2M | -23% | Sep 2023 |
|
Sofinnova Ventures | 143k | $720k | 0% | Sep 2023 |
|
Two Sigma Advisers | 109k | $542k | -57% | Dec 2023 |
|
Bank of New York Mellon | 108k | $536k | -1% | Dec 2023 |
|
Nuveen Asset Management | 105k | $531k | 0% | Sep 2023 |
|
Bank of America Corporation | 85k | $422k | 183% | Dec 2023 |
|
Charles Schwab Investment Management | 77k | $384k | 0% | Dec 2023 |
|
Commonwealth Equity Services | 77k | $383k | 16% | Dec 2023 |
|
Amussen Hunsaker & Associates | 75k | $377k | 0% | Sep 2023 |
|
Morgan Stanley | 69k | $348k | 2% | Sep 2023 |
|
Caption Management | 58k | $289k | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 52k | $256k | 0% | Dec 2023 |
|
D. E. Shaw & Co | 50k | $247k | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 42k | $210k | -4% | Dec 2023 |
|
Group One Trading | 41k | $208k | 16% | Sep 2023 |
|
Vontobel Holding | 41k | $204k | 0% | Dec 2023 |
|
Two Sigma Investments | 41k | $202k | -68% | Dec 2023 |
|
Barclays | 38k | $191k | 681% | Dec 2023 |
|
Alliancebernstein | 38k | $188k | 0% | Dec 2023 |
|
Rhumbline Advisers | 34k | $168k | 4% | Dec 2023 |
|
AQR Capital Management | 29k | $145k | 30% | Dec 2023 |
|
Verition Fund Management | 26k | $130k | -17% | Sep 2023 |
|
Nebula Research & Development | 26k | $130k | -26% | Sep 2023 |
|
Simplex Trading | 25k | $124k | -40% | Dec 2023 |
|
Virtu Financial | 25k | $124k | 100% | Dec 2023 |
|
Raymond James & Associates | 24k | $121k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 22k | $107k | 26% | Dec 2023 |
|
Jane Street | 20k | $101k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 20k | $100k | 11% | Dec 2023 |
|
Invesco | 20k | $101k | 12% | Sep 2023 |
|
UBS Group | 16k | $79k | 3229% | Dec 2023 |
|
T. Rowe Price Associates | 16k | $79k | 8% | Dec 2023 |
|
Corton Capital | 15k | $75k | -31% | Dec 2023 |
|
Rathbones Brothers | 15k | $76k | 100% | Sep 2023 |
|
MetLife Investment Advisors | 15k | $74k | 0% | Dec 2023 |
|
American International | 14k | $69k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 14k | $68k | -23% | Dec 2023 |
|
Squarepoint Ops | 13k | $65k | 17% | Dec 2023 |
|
Millennium Management | 13k | $63k | 100% | Dec 2023 |
|
Mercer Global Advisors | 13k | $62k | 0% | Dec 2023 |
|
Goldman Sachs Group | 13k | $62k | -6% | Dec 2023 |
|
Manufacturers Life Insurance Company | 12k | $61k | 0% | Sep 2023 |
|
Lazari Capital Management | 12k | $60k | 9% | Dec 2023 |
|
Ing Investment Management | 11k | $57k | 0% | Sep 2023 |
|
Royal Bank of Canada | 11k | $55k | 91% | Dec 2023 |
|
SG Americas Securities | 11k | $52k | 100% | Dec 2023 |
|
EP Wealth Advisors | 10k | $51k | 0% | Dec 2023 |
|
Wells Fargo & Company | 7.3k | $36k | 22% | Dec 2023 |
|
California State Teachers Retirement System | 6.2k | $31k | -34% | Sep 2023 |
|
Citigroup | 4.0k | $20k | 23512% | Dec 2023 |
|
Amalgamated Bank | 4.0k | $20k | -7% | Dec 2023 |
|
Legal & General Group | 3.0k | $15k | -12% | Dec 2023 |
|
Summit Investment Advisors | 2.3k | $12k | 0% | Dec 2023 |
|
Metropolitan Life Insurance Company | 1.5k | $7.7k | 0% | Dec 2023 |
|
FMR | 1.5k | $7.7k | -19% | Sep 2023 |
|
Tower Research Capital | 1.4k | $7.2k | -45% | Sep 2023 |
|
Truvestments Capital | 1.4k | $6.9k | 0% | Sep 2023 |
|
New York State Common Retirement Fund | 931.00 | $5.0k | -94% | Dec 2023 |
|
Lindbrook Capital | 500.00 | $2.5k | 0% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 400.00 | $1.0k | 0% | Dec 2023 |
|
JJJ Advisors | 287.00 | $1.4k | 0% | Dec 2023 |
|
Advisor Group Holdings | 250.00 | $1.2k | -96% | Dec 2023 |
|
ICA Group Wealth Management | 125.00 | $621.000000 | 100% | Dec 2023 |
|
CWM | 61.00 | $0 | 100% | Dec 2023 |
|
Pnc Financial Services | 8.00 | $40.000000 | 100% | Dec 2023 |
|
Who sold out of Pds Biotechnology Ord?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Marshall Wace | Sep 2023 | 69k | $347k |
Trexquant Investment | Sep 2023 | 26k | $131k |
Occudo Quantitative Strategies | Sep 2023 | 24k | $123k |
Renaissance Technologies | Jun 2023 | 23k | $115k |
ALPS Advisors | Sep 2023 | 23k | $115k |
Winton Capital | Sep 2023 | 21k | $107k |
Jump Financial | Sep 2023 | 17k | $86k |
Cetera Investment Advisers | Jun 2023 | 12k | $62k |
Raymond James Financial Services Advisors | Sep 2023 | 11k | $56k |
Kennedy Capital Management | Sep 2023 | 10k | $53k |
Cary Street Partner Investment Advisory | Sep 2023 | 6.1k | $31k |
Allspring Global Investments Holdings | Sep 2023 | 6.0k | $30k |
Goss Wealth Management | Jun 2023 | 427.00 | $2.1k |
Russell Investments | Sep 2023 | 109.00 | $550.003100 |
IFP Advisors | Sep 2023 | 11.00 | $55.999900 |